AE Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,223
Closed -$206K 2206
2025
Q1
$206K Buy
+3,223
New +$187K ﹤0.01% 1268
2024
Q1
Sell
-8,372
Closed -$286K 1500
2023
Q4
$286K Buy
+8,372
New +$315K ﹤0.01% 1728
2023
Q2
Sell
-6,822
Closed -$261K 1971
2023
Q1
$261K Buy
+6,822
New +$320K ﹤0.01% 1618

Other funds holding HALO

AE Wealth Management's HALO Position: Q2 2025 in Review

AE Wealth Management sold out of Halozyme (HALO) in Q2 2025, closing a stake of 3,223 shares — an estimated $206K sold.

AE Wealth Management first reported a position in HALO in Q1 2023 and held it in 3 quarters. The position peaked at $286K in Q4 2023. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • AE Wealth Management reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • AE Wealth Management sold 3,223 Halozyme shares in Q2 2025, an estimated $206K.
  • AE Wealth Management first reported a position in Halozyme in Q1 2023 and held it in 3 quarters.
  • AE Wealth Management's Halozyme position peaked at $286K in Q4 2023.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on AE Wealth Management's 13F filing for Q2 2025, filed 6 Aug 2025.